CN Patent

CN115916212A — 曲前列尼尔用于治疗间质性肺病

Assigned to United Therapeutics Corp · Expires 2023-04-04 · 3y expired

What this patent protects

本公开提供了治疗间质性肺病、减轻患有间质性肺病(ILD)受试者的肺功能下降和增加患有ILD的受试者用力肺活量(FVC)的方法，其中所述方法包括施用曲前列尼尔。

USPTO Abstract

本公开提供了治疗间质性肺病、减轻患有间质性肺病(ILD)受试者的肺功能下降和增加患有ILD的受试者用力肺活量(FVC)的方法，其中所述方法包括施用曲前列尼尔。

Drugs covered by this patent

Patent Metadata

Patent number
CN115916212A
Jurisdiction
CN
Classification
—
Expires
2023-04-04
Drug substance claim
No
Drug product claim
No
Assignee
United Therapeutics Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.